Search research articles
Contact Us
Filters
Showing results (261-270 of 587) with videos related to
Page
of 59
Sort By:
Endocrine Connections
|
January 22, 2020
Factors associated with resistance to complications in long-standing type 1 diabetes in China
Wei Liu, Yanai Wang, Xueyao Han, et al.
Endocrine Connections
|
September 22, 2022
Preserved C-peptide secretion is associated with higher time in range (TIR) on intermittently scanned continuous glucose monitoring in Chinese adults with type 1 diabetes
Wei Liu, Yunke Ma, Xiaoling Cai, et al.
Expert Opinion on Investigational Drugs
|
August 15, 2022
Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participants
Zonglin Li, Chu Lin, Jinyu Zhou, et al.
Diabetes, Obesity & Metabolism
|
February 22, 2023
Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: An analysis using national cross-sectional data
Chu Lin, Xingyun Zhu, Ruoyang Jiao, et al.
Diabetes Research and Clinical Practice
|
May 4, 2021
Comparison of insulin glargine 300 U/mL versus glargine 100 U/mL on glycemic control and hypoglycemic events in East Asian patients with type 2 diabetes: A Patient-level meta-analysis of phase 3 studies
Linong Ji, Yan Bi, Shandong Ye, et al.
Annals of Medicine
|
December 13, 2025
Intensive blood pressure reduction but an increased risk of peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials
Ruoyang Jiao, Chu Lin, Zonglin Li, et al.
Cell & Bioscience
|
August 22, 2023
Differential effects of PGAM5 knockout on high fat high fructose diet and methionine choline-deficient diet induced non-alcoholic steatohepatitis (NASH) in mice
Li Li, Chengcheng Guo, Yue Yu, et al.
Cell Reports. Medicine
|
April 9, 2026
GZR18, a GLP-1 analog with once-weekly or bi-weekly dosing for body weight management: A randomized, placebo-controlled, phase 1b/2a trial
Linong Ji, Leili Gao, Ruihua Dong, et al.
European Journal of Internal Medicine
|
January 11, 2023
Is the steady-state concentration, duration of action, or molecular weight of GLP-1RA associated with cardiovascular and renal outcomes in type 2 diabetes?
Shuzhen Bai, Chu Lin, Ruoyang Jiao, et al.
Diabetes Research and Clinical Practice
|
June 2, 2009
Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population
Yingying Luo, Hongyuan Wang, Xueyao Han, et al.
Page
of 59
Search research articles
Search
Showing results (261-270 of 587) with videos related to
Sort By:
Page
of 59
Endocrine Connections
|
January 22, 2020
Factors associated with resistance to complications in long-standing type 1 diabetes in China
Wei Liu, Yanai Wang, Xueyao Han, et al.
Endocrine Connections
|
September 22, 2022
Preserved C-peptide secretion is associated with higher time in range (TIR) on intermittently scanned continuous glucose monitoring in Chinese adults with type 1 diabetes
Wei Liu, Yunke Ma, Xiaoling Cai, et al.
Expert Opinion on Investigational Drugs
|
August 15, 2022
Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participants
Zonglin Li, Chu Lin, Jinyu Zhou, et al.
Diabetes, Obesity & Metabolism
|
February 22, 2023
Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: An analysis using national cross-sectional data
Chu Lin, Xingyun Zhu, Ruoyang Jiao, et al.
Diabetes Research and Clinical Practice
|
May 4, 2021
Comparison of insulin glargine 300 U/mL versus glargine 100 U/mL on glycemic control and hypoglycemic events in East Asian patients with type 2 diabetes: A Patient-level meta-analysis of phase 3 studies
Linong Ji, Yan Bi, Shandong Ye, et al.
Annals of Medicine
|
December 13, 2025
Intensive blood pressure reduction but an increased risk of peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials
Ruoyang Jiao, Chu Lin, Zonglin Li, et al.
Cell & Bioscience
|
August 22, 2023
Differential effects of PGAM5 knockout on high fat high fructose diet and methionine choline-deficient diet induced non-alcoholic steatohepatitis (NASH) in mice
Li Li, Chengcheng Guo, Yue Yu, et al.
Cell Reports. Medicine
|
April 9, 2026
GZR18, a GLP-1 analog with once-weekly or bi-weekly dosing for body weight management: A randomized, placebo-controlled, phase 1b/2a trial
Linong Ji, Leili Gao, Ruihua Dong, et al.
European Journal of Internal Medicine
|
January 11, 2023
Is the steady-state concentration, duration of action, or molecular weight of GLP-1RA associated with cardiovascular and renal outcomes in type 2 diabetes?
Shuzhen Bai, Chu Lin, Ruoyang Jiao, et al.
Diabetes Research and Clinical Practice
|
June 2, 2009
Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population
Yingying Luo, Hongyuan Wang, Xueyao Han, et al.
Page
of 59